Phosphagenics Ltd. ADR | |
Stock Exchange | Other OTC |
EPS |
$0.1 |
Market Cap |
$25.9 M |
Shares Outstanding |
- |
Public Float |
- |
Phosphagenics Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0 |
Market Cap |
AUD36.28 M |
Shares Outstanding |
1.58 B |
Public Float |
- |
Address |
Unit A8 Clayton Victoria (VIC) 3168 Australia |
Employees | - |
Website | http://www.phosphagenics.com |
Updated | 09/14/2018 |
Phosphagenics Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. It operates through the following business segments: Production and Personal Care; Human Health; and All Other. The Production and Personal Care segment manufactures and sells TPM and Vital ET. |